tapentadol   Click here for help

GtoPdb Ligand ID: 7477

Synonyms: BN-200 | CG-5503 | Nucynta® | Palexia®
Approved drug
tapentadol is an approved drug (FDA (2008))
Compound class: Synthetic organic
Comment: The marketed formulation contains tapentadol hydrochloride (PubChem CID 9838021).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 23.47
Molecular weight 221.18
XLogP 3.25
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(c1cccc(c1)O)C(CN(C)C)C
Isomeric SMILES CC[C@@H](c1cccc(c1)O)[C@H](CN(C)C)C
InChI InChI=1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1
InChI Key KWTWDQCKEHXFFR-SMDDNHRTSA-N
No information available.
Summary of Clinical Use Click here for help
Tapentadol is approved to treat moderate to severe pain.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Tapentadol functions as a μ-opioid receptor agonist and as an inhibitor of norepinephrine reuptake via the norepinephrine transporter (NET) [1-2]. It is hypothesised that combining μ-opioid receptor agonist activity with enhanced monoamine activity (eg by inhibiting NET) additively/synergistically enhances the analgesic efficacy of selectve μ-opioid receptor agonists and may reduce their side effects [2] .
External links Click here for help